Last reviewed · How we verify
NCT07387237
Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal
trial in Gastric Cancer (Diagnosis) in 51 participants. Completed in 1 September 2025.
1 August 2025
Quick facts
| Lead sponsor | Unidade Local De Saúde Do Norte Alentejano |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 51 |
| Start date | 20 September 2023 |
| Primary completion | 1 August 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across Portugal |
Conditions studied
- Gastric Cancer (Diagnosis) — all drugs for Gastric Cancer (Diagnosis) →
- Stomach Cancer — all drugs for Stomach Cancer →
Sponsor
Unidade Local De Saúde Do Norte Alentejano
Who can join
18 and older, any sex, with Gastric Cancer (Diagnosis) or Stomach Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multigene germeline panel test in gastric cancer patients
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Multigene Germline Panel Testing in Gastric Cancer Patients in a Portuguese Population.
Mourato B, Cordeiro B, Costa Pinto F, Pratas N, et al · · 2026 · PMID 41853923 · DOI 10.1002/cam4.71732
Verify or expand the search:
- PubMed search for NCT07387237
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastric Cancer (Diagnosis)
Currently open trials in the same condition.
- NCT07401173 — DeepComp for Prediction of Gastric Cancer Postoperative Complications (DeepComp-Prospective) · recruiting
- NCT07307560 — High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients · NA · recruiting
- NCT07481110 — Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria · recruiting
- NCT07517432 — The UGIRA International Registry for RAMIG for Gastric Cancer · recruiting
Other Unidade Local De Saúde Do Norte Alentejano trials
Trials by the same sponsor.
- NCT07522320 — Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management · active not recruiting
- NCT06316882 — Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07387237 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unidade Local De Saúde Do Norte Alentejano
- Last refreshed: 4 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07387237.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing